SKU:BT-MCA0962
OTX2 Monoclonal Antibody
OTX2 Monoclonal Antibody
This gene encodes a member of the bicoid subfamily of homeodomain-containing transcription factors. The encoded protein acts as a transcription factor and plays a role in brain, craniofacial, and sensory organ development. The encoded protein also influences the proliferation and differentiation of dopaminergic neuronal progenitor cells during mitosis. Mutations in this gene cause syndromic microphthalmia 5 (MCOPS5) and combined pituitary hormone deficiency 6 (CPHD6). This gene is also suspected of having an oncogenic role in medulloblastoma. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Pseudogenes of this gene are known to exist on chromosomes two and nine.
Introducing the OTX2 Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of medical research and diagnostics. This highly specialized antibody is meticulously engineered to target and bind to the OTX2 protein, a crucial transcription factor involved in the regulation of embryonic development and cell differentiation.
Crafted with utmost precision and utilizing state-of-the-art technology, the OTX2 Monoclonal Antibody offers unparalleled specificity and sensitivity, enabling researchers and clinicians to accurately detect and quantify OTX2 protein expression in various biological samples. Its exceptional affinity for the OTX2 protein ensures reliable and reproducible results, facilitating a deeper understanding of its role in physiological and pathological processes.
The OTX2 Monoclonal Antibody boasts exceptional versatility, making it an invaluable tool across a wide range of applications. From fundamental research in developmental biology and neuroscience to clinical investigations in oncology and neurodegenerative disorders, this antibody empowers scientists and medical professionals to unravel the intricate mechanisms underlying complex diseases and pave the way for innovative therapeutic interventions.
Furthermore, the OTX2 Monoclonal Antibody is manufactured in compliance with rigorous quality standards, ensuring consistent performance and reliability. Each batch undergoes meticulous quality control procedures to guarantee batch-to-batch consistency, minimizing experimental variability and maximizing research reproducibility.
In summary, the OTX2 Monoclonal Antibody represents a breakthrough in the field of biotechnology, offering researchers and clinicians an indispensable tool to unravel the mysteries of OTX2 protein function. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to drive advancements in medical research and diagnostics, ultimately leading to improved patient outcomes and a deeper understanding of human biology.